Rational Advisors’s Accendra Health ACH Stock Holding History

Rational Advisors’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-30,900	Closed	-$481K	–	550
2018 Q1	$481K	Buy	+30,900	New	+$551K	0.23%	139
2016 Q4	–	Sell	-13,300	Closed	-$462K	–	284
2016 Q3	$462K	Sell	13,300 -49,500	-79%	-$1.73M	0.3%	107
2016 Q2	$2.35M	Hold	62,800	–	–	1.63%	13
2016 Q1	$2.54M	Buy	+62,800	New	+$2.34M	1.66%	11

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Rational Advisors's ACH Position: Q2 2018 in Review

Rational Advisors sold out of Accendra Health (ACH) in Q2 2018, closing a stake of 30,900 shares — an estimated $481K sold.

Rational Advisors first reported a position in ACH in Q1 2016 and held it in 4 quarters. The position peaked at $2.54M in Q1 2016. 229 funds tracked by Wall St. Rank hold ACH as of Q2 2018.

Rational Advisors reported no remaining Accendra Health position as of Q2 2018 after selling out during the quarter.
Rational Advisors sold 30,900 Accendra Health shares in Q2 2018, an estimated $481K.
Rational Advisors first reported a position in Accendra Health in Q1 2016 and held it in 4 quarters.
Rational Advisors's Accendra Health position peaked at $2.54M in Q1 2016.
229 funds tracked by Wall St. Rank held Accendra Health as of Q2 2018.

Based on Rational Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.